418 related articles for article (PubMed ID: 18977436)
1. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
3. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ibuprofen release from minitablets and capsules containing ibuprofen: β-cyclodextrin complex.
Salústio PJ; Cabral-Marques HM; Costa PC; Pinto JF
Eur J Pharm Biopharm; 2011 May; 78(1):58-66. PubMed ID: 21195175
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
7. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
9. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl-beta-cyclodextrin on Wistar rats: histopathologic analysis.
Ribeiro-Rama AC; Figueiredo IV; Veiga F; Castel-Branco MM; Cabrita AM; Caramona MM
Fundam Clin Pharmacol; 2009 Dec; 23(6):747-55. PubMed ID: 19656206
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
12. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
[TBL] [Abstract][Full Text] [Related]
13. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
14. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives.
Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438
[TBL] [Abstract][Full Text] [Related]
16. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
17. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
18. Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel.
Xin J; Guo Z; Chen X; Jiang W; Li J; Li M
Int J Pharm; 2010 Feb; 386(1-2):221-8. PubMed ID: 19945520
[TBL] [Abstract][Full Text] [Related]
19. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
[TBL] [Abstract][Full Text] [Related]
20. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
